Colorectal Surgery Market Insights by Indications and End-use Segments

The global colorectal surgery market was valued at USD 6.0 billion in 2024 and is projected to reach USD 9.8 billion by 2033, registering a CAGR of 5.6% from 2025 to 2033. Market expansion is driven by the growing incidence of colorectal diseases, technological advancements in surgical procedures, favorable regulatory frameworks, and strong government-led initiatives promoting screening and early intervention.

A rising prevalence of colorectal cancer—along with conditions such as inflammatory bowel disease (IBD) and diverticulitis—is substantially increasing demand for colorectal surgical interventions. According to the World Cancer Research Fund, global colorectal cancer incidence reached 1,926,425 cases in 2022, with an ASR of 18.4 per 100,000 individuals. Of these, men accounted for 1,069,446 cases (ASR: 22.0) and women 856,979 cases (ASR: 15.2). The disease led to 904,019 deaths worldwide, with men experiencing 499,755 deaths (ASR: 9.9) and women 404,244 deaths (ASR: 6.5). Lifestyle-related factors—including increasing rates of obesity, poor dietary patterns, and sedentary behavior—continue to contribute to rising incidence levels. At the same time, greater public health awareness, education, and promotion of routine screening are expected to support market growth through earlier diagnosis and more timely treatment.

Key Market Trends & Insights

• North America was the largest revenue-generating regional market in 2024.
• The endoscopes segment led the market by product category, holding 28.5% share in 2024.
• By surgery type, right hemicolectomy accounted for the largest share at 22.8% in 2024.
• Colorectal cancer remained the dominant segment by indication.
• Hospitals & clinics served as the primary end-use category in 2024.

Download a free sample PDF of the Colorectal Surgery Market Intelligence Study by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 6.0 Billion
• 2033 Projected Market Size: USD 9.8 Billion
• CAGR (2025–2033): 5.6%
• Leading Region (2024): North America

Competitive Landscape

The global colorectal surgery market is characterized by the presence of major medical device and technology companies with strong R&D capabilities. These players continue to broaden their clinical offerings through product innovation, strategic partnerships, and mergers & acquisitions, enabling them to strengthen their market positions and meet evolving clinical needs.

Prominent Companies

• Intuitive Surgical
• Medtronic plc
• Johnson & Johnson
• Stryker Corporation
• Olympus Corporation
• CONMED Corporation
• B. Braun SE
• Karl Storz SE & Co. KG
• Boston Scientific Corporation

Recent Developments

• January 2025: Panakeia introduced PANProfiler Colon, an AI-powered tool that rapidly determines MSI and dMMR status directly from H&E-stained colon cancer tissue samples, enabling faster molecular profiling and more personalized treatment decisions.
• October 2024: The FDA approved Exact Sciences’ Cologuard Plus, an advanced non-invasive colorectal cancer screening test for adults aged 45 and older at average risk. With 95% sensitivity for colorectal cancer and 94% specificity, the test represents a major advancement in convenient, early detection solutions.

Explore Horizon Databook – the world’s most comprehensive market intelligence platform by Grand View Research.

Conclusion

The colorectal surgery market is set for steady growth due to rising disease prevalence, technological innovation, and expanding screening initiatives. As healthcare systems emphasize early detection and minimally invasive surgical approaches, demand for advanced colorectal surgical tools and solutions is expected to accelerate through 2033.